Return to homepagePandemic Pact

Development of serological methods for the diagnosis of SARS-COV2 (Covid-19)

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    University of São Paulo

  • Principal Investigator

    Prof and Prof and Dr and Dr Esther and Maria Cassia Jacintho and Tania and Kelly and Mussya Cisotto Sabino and Mendes Correa and Tozetto and Kanunfre and Rocha

  • Research Location

    Brazil

  • Lead Research Institution

    Institute of Biomedical Sciences - University of São Paulo (ICB-USP), Institute of Tropical Medicine University of São Paulo

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Submission of two research projects to CAPPesq, via Plataforma Brasil, on the development of serological methods for the diagnosis of SARS-COV2 (Covid-19). In partnership with ICB-USP (Prof. Luiz Durigon), two laboratories of the Institute of Tropical Medicine are developing serological tests, based on viral cultures in cells obtained by ICB-USP. We intend to make available, as soon as possible, serological tests (ELISA and IFI) aimed at the diagnosis of Covid-19, since Rt-PCR, although very sensitive and specific, cannot be performed on the scale expected in an epidemic. Responsible: Prof. Thelma Suely Okay, from FMUSP